Skip to main content
OLYMPUS CORPORATION logo

OLYMPUS CORPORATION — Investor Relations & Filings

Ticker · 7733 ISIN · JP3201200007 LEI · 5299000Y52IFDI1I2A21 T Manufacturing
Open in API
Filings indexed 102 across all filing types
Latest filing 2021-06-21 Governance Information
Country JP Japan
Listing T 7733

About OLYMPUS CORPORATION

https://www.olympus-global.com/

Olympus Corporation is a global medical technology (medtech) company focused on making people's lives healthier, safer, and more fulfilling. The company develops, manufactures, and commercializes innovative solutions for the medical and healthcare sectors, specializing in early detection, diagnosis, and minimally invasive treatment. Its core product portfolio includes medical endoscopes, endotherapy devices, and therapeutic energy devices. These technologies are applied across various medical specialties such as gastroenterology, urology, gynecology, and general surgery. Leveraging its expertise in optical and digital precision technology, Olympus provides comprehensive solutions that also encompass advanced video imaging systems and system integration services for healthcare facilities.

Recent filings

Filing Released Lang Actions
内部統制報告書－第153期(令和2年4月1日－令和3年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed by Olympus Corporation in accordance with the Financial Instruments and Exchange Act of Japan. This type of report details the framework, scope, and effectiveness of a company's internal controls over financial reporting. Since it is a specific regulatory filing regarding internal control systems and does not fit into the other categories like 10-K (Annual Report) or ER (Earnings Release), it falls under the 'Regulatory Filings' category.
2021-06-21 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, Article 24-4-2, Paragraph 1. This is a mandatory internal control certification document that accompanies the Annual Securities Report (Yukashoken Hokokusho) in Japan. Since it is a regulatory filing confirming the accuracy of the annual report and does not constitute the annual report itself, it falls under the general regulatory filings category. FY 2021
2021-06-21 Japanese
有価証券報告書－第153期(令和2年4月1日－令和3年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of an Annual Report (10-K). It contains comprehensive financial data, business information, and is filed under the Financial Instruments and Exchange Act (Article 24, Paragraph 1). The metadata confirms it covers the fiscal year ending March 31, 2021, and includes detailed financial statements and disclosures. FY 2021
2021-06-21 Japanese
四半期報告書－第153期第3四半期(令和2年10月1日－令和2年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Olympus Corporation, covering the third quarter of the fiscal year ending March 2021. It contains detailed financial statements, management analysis, and business segment performance, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-02-12 Japanese
Olympus Acquires Veran Medical Technologies, Inc.
Regulatory Filings Classification · 98% confidence The document is a press release announcing that Olympus Corporation has entered into an agreement to acquire Veran Medical Technologies, Inc. This is a clear announcement of a merger and acquisition (M&A) transaction. While it is distributed via RNS (a regulatory news service), the content is specifically focused on the acquisition details, strategic rationale, and the target company's profile, which fits the definition of M&A activity (TAR).
2020-12-04 English
四半期報告書－第153期第2四半期(令和2年7月1日－令和2年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Olympus Corporation, covering the second quarter of the fiscal year ending March 2021. It contains detailed financial statements, management analysis (MD&A), and segment reporting, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2021
2020-11-13 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.